Results
Latest quarterly results
Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.
SectorAll 3892Healthcare 878Financial Services 629Technology 560Industrials 517Consumer Cyclical 330Basic Materials 232Energy 196Communication Services 168Real Estate 161Consumer Defensive 134Utilities 87
| Company | Sector | Reported | Quarter | Revenue | Rev. YoY | Net income | NI YoY | EPS | EPS YoY | Op. margin | Margin chg. | Market cap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GNPXGenprex, Inc. | Healthcare | Nov 13 | Sep '26 | $0.0M | n/m | −$4.0M | n/m | −$5.30 | n/m | — | — | $843,494 |
| IMCCIM Cannabis Corp. | Healthcare | Nov 13 | Sep '26 | $1.1M | n/m | — | n/m | −$18.51 | n/m | -184.4% | — | $813,367 |
| ASNDAscendis Pharma A/S - Ordinary Share | Healthcare | Nov 12 | Sep '26 | $419M | +71.5% | — | n/m | $1.24 | n/m | 33.7% | +28.6 pp | $17.8B |
| TWSTTwist Bioscience Corporation | Healthcare | Nov 12 | Sep '26 | $127M | +28.3% | −$21.0M | n/m | −$0.31 | n/m | -25.0% | +5.3 pp | $7.4B |
| KODKodiak Sciences Inc | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | $124M | n/m | −$1.05 | n/m | — | — | $6.3B |
| ARWRArrowhead Pharmaceuticals, Inc. | Healthcare | Nov 12 | Sep '26 | $38.0M | n/m | −$428M | n/m | −$3.02 | n/m | — | — | $6.1B |
| ERASErasca, Inc. | Healthcare | Nov 12 | Sep '26 | $1.0M | n/m | −$51.0M | n/m | −$0.13 | n/m | — | — | $4.9B |
| HTFLHeartflow, Inc. | Healthcare | Nov 12 | Sep '26 | $73.0M | +58.7% | −$12.0M | n/m | −$0.13 | n/m | -19.0% | +13.6 pp | $4.1B |
| SLSSELLAS Life Sciences Group, Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$10.0M | n/m | −$0.05 | n/m | — | — | $3.9B |
| PBLSParabilis Medicines, Inc. | Healthcare | Nov 12 | Sep '26 | $2.0M | — | −$44.0M | — | −$0.36 | — | — | — | $3.4B |
| AVAHAveanna Healthcare Holdings Inc. | Healthcare | Nov 12 | Sep '26 | $696M | +11.9% | $45.0M | +221.4% | $0.20 | +233.3% | 12.0% | +3.0 pp | $2.5B |
| PHVSPharvaris N.V. | Healthcare | Nov 12 | Sep '26 | — | n/m | — | n/m | −$0.77 | n/m | — | — | $2.3B |
| ADRXADARx Pharmaceuticals, Inc. | Healthcare | Nov 12 | Sep '26 | $2.0M | — | −$28.0M | — | −$0.27 | — | — | — | $1.5B |
| ANABAnaptysBio, Inc. | Healthcare | Nov 12 | Sep '26 | $30.0M | −60.5% | $4.0M | −73.3% | $0.11 | −78.8% | 65.8% | +20.3 pp | $1.4B |
| ABSIAbsci Corporation | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$33.0M | n/m | −$0.19 | n/m | — | — | $1.3B |
| TSHATaysha Gene Therapies, Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$39.0M | n/m | −$0.10 | n/m | — | — | $1.3B |
| GENBGenerate Biomedicines, Inc. | Healthcare | Nov 12 | Sep '26 | $4.0M | — | −$88.0M | — | −$0.68 | — | — | — | $1.3B |
| AVLNAvalyn Pharma Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | — | −$30.0M | — | $0.00 | — | — | — | $1.2B |
| KARDKardigan, Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | — | −$59.0M | — | −$0.64 | — | — | — | $1.2B |
| NKTRNektar Therapeutics | Healthcare | Nov 12 | Sep '26 | $9.0M | −25.0% | −$56.0M | n/m | −$1.63 | n/m | -615.8% | −348.4 pp | $1.0B |
| AKTSAktis Oncology, Inc. | Healthcare | Nov 12 | Sep '26 | $4.0M | +100.0% | −$30.0M | n/m | −$0.54 | n/m | -889.8% | — | $877M |
| MGTXMeiraGTx Holdings plc | Healthcare | Nov 12 | Sep '26 | $5.0M | n/m | −$51.0M | n/m | −$0.53 | n/m | — | — | $827M |
| PRMEPrime Medicine, Inc. | Healthcare | Nov 12 | Sep '26 | $4.0M | +300.0% | −$39.0M | n/m | −$0.22 | n/m | -947.7% | — | $699M |
| SGMTSagimet Biosciences Inc. - Series A | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$19.0M | n/m | −$0.31 | n/m | — | — | $693M |
| ALMSAlumis Inc. | Healthcare | Nov 12 | Sep '26 | $2.0M | 0.0% | −$95.0M | n/m | −$0.73 | n/m | — | — | $626M |
| IMMXImmix Biopharma, Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$14.0M | n/m | −$0.19 | n/m | — | — | $603M |
| FDMT4D Molecular Therapeutics, Inc. | Healthcare | Nov 12 | Sep '26 | $4.0M | n/m | −$78.0M | n/m | −$1.08 | n/m | — | — | $596M |
| CBIOCrescent Biopharma, Inc. | Healthcare | Nov 12 | Sep '26 | $3.0M | n/m | −$38.0M | n/m | −$0.97 | n/m | — | — | $507M |
| MNPRMonopar Therapeutics Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$6.0M | n/m | −$0.72 | n/m | — | — | $482M |
| FENCFennec Pharmaceuticals Inc. | Healthcare | Nov 12 | Sep '26 | $20.0M | +66.7% | $5.0M | n/m | $0.12 | n/m | 23.7% | +25.4 pp | $479M |
| ASMBAssembly Biosciences, Inc. | Healthcare | Nov 12 | Sep '26 | $3.0M | n/m | −$20.0M | n/m | −$0.93 | n/m | -792.1% | — | $461M |
| DMACDiaMedica Therapeutics Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$11.0M | n/m | −$0.21 | n/m | — | — | $452M |
| BLSMBlossomHill Therapeutics, Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | — | −$24.0M | — | −$0.88 | — | — | — | $440M |
| CRMDCorMedix Inc. | Healthcare | Nov 12 | Sep '26 | $55.0M | −47.1% | −$15.0M | −113.8% | −$0.19 | −115.1% | -12.1% | −61.4 pp | $371M |
| PROKProKidney Corp. | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$36.0M | n/m | −$0.17 | n/m | — | — | $370M |
| CVCapsoVision, Inc. | Healthcare | Nov 12 | Sep '26 | $4.0M | 0.0% | −$7.0M | n/m | −$0.15 | n/m | -206.9% | −209.7 pp | $357M |
| RLMDRelmada Therapeutics, Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$14.0M | n/m | −$0.12 | n/m | — | — | $321M |
| SMTISanara MedTech Inc. | Healthcare | Nov 12 | Sep '26 | $28.0M | +7.7% | −$1.0M | n/m | −$0.16 | n/m | 2.6% | −8.7 pp | $301M |
| ALTAltimmune, Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$32.0M | n/m | −$0.15 | n/m | — | — | $298M |
| KYTXKyverna Therapeutics, Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$42.0M | n/m | −$0.68 | n/m | — | — | $297M |
| EVMNEvommune, Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | −100.0% | −$31.0M | n/m | −$0.85 | n/m | — | — | $290M |
| FULCFulcrum Therapeutics, Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$11.0M | n/m | −$0.14 | n/m | — | — | $286M |
| NPCENeuropace, Inc. | Healthcare | Nov 12 | Sep '26 | $23.0M | −14.8% | −$3.0M | n/m | −$0.10 | n/m | -9.0% | +0.5 pp | $283M |
| EIKNEikon Therapeutics, Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$86.0M | n/m | −$1.59 | n/m | — | — | $279M |
| SCTXScribe Therapeutics Inc. | Healthcare | Nov 12 | Sep '26 | $2.0M | — | −$10.0M | — | −$0.52 | — | -663.9% | — | $255M |
| IPSCCentury Therapeutics, Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$23.0M | n/m | −$0.11 | n/m | — | — | $249M |
| RCKTRocket Pharmaceuticals, Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | n/m | −$49.0M | n/m | −$0.43 | n/m | — | — | $236M |
| LCTXLineage Cell Therapeutics, Inc. | Healthcare | Nov 12 | Sep '26 | $1.0M | n/m | $4.0M | n/m | −$0.03 | n/m | -510.0% | — | $206M |
| ETRAElectra Therapeutics Inc. | Healthcare | Nov 12 | Sep '26 | $0.0M | — | −$24.0M | — | −$0.38 | — | — | — | $177M |
| MDWDMediWound Ltd. | Healthcare | Nov 12 | Sep '26 | $4.0M | −20.0% | −$6.0M | n/m | −$0.46 | n/m | -239.3% | −119.1 pp | $177M |
- Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
- YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
- pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.